Key facts
- Redmile Group, LLC filed SCHEDULE 13D/A for Absci Corporation Common Stock, $0.0001 par value per share (ABSI).
- Disclosed ownership: 6.5%.
- Date of event: 25 Apr 2025.
Redmile Group, LLC - 25 Apr 2025 SCHEDULE 13D/A Report for Absci Corporation Common Stock, $0.0001 par value per share (ABSI)
- Filing Manager
- Redmile Group, LLC
- Reporting Manager
- Redmile Group, LLC
- Symbol
- ABSI
- Shares outstanding
- 128,232,554 shares
- Disclosed Ownership
- 8,335,116 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13D/A
- Filing time
- 29 Apr 2025, 21:31:04 UTC
- Date of event
- 25 Apr 2025
- Next filing
- 26 Mar 2026
- SEC
- View on sec.gov
Key filing fact
Redmile Group, LLC disclosed 6.5% ownership in Absci Corporation Common Stock, $0.0001 par value per share (ABSI) on 25 Apr 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Apr 2025, 21:31.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 6.5% | 8,335,116 | 0 | 8,335,116 | /s/ Jeremy C. Green | Managing Member | 0001425738 |
| Jeremy C. Green | 6.5% | 8,335,116 | 0 | 8,335,116 | /s/ Jeremy C. Green | Jeremy C. Green | 0001650527 |
| Redmile Biopharma Investments II, L.P. | 4.9% | 6,267,205 | 0 | 6,267,205 | /s/ Jeremy C. Green | Managing Member of Redmile Biopharma Investments II (GP), LLC, general partner of Redmile Biopharma Investments II, L.P. | 0001772230 |
CIK / CUSIP context first